1-67321603-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001374259.2(IL12RB2):​c.78T>C​(p.Asp26Asp) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0109 in 1,589,766 control chromosomes in the GnomAD database, including 1,638 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.057 ( 845 hom., cov: 32)
Exomes 𝑓: 0.0060 ( 793 hom. )

Consequence

IL12RB2
NM_001374259.2 splice_region, synonymous

Scores

2
Splicing: ADA: 0.0001872
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.01

Publications

9 publications found
Variant links:
Genes affected
IL12RB2 (HGNC:5972): (interleukin 12 receptor subunit beta 2) The protein encoded by this gene is a type I transmembrane protein identified as a subunit of the interleukin 12 receptor complex. The coexpression of this and IL12RB1 proteins was shown to lead to the formation of high-affinity IL12 binding sites and reconstitution of IL12 dependent signaling. The expression of this gene is up-regulated by interferon gamma in Th1 cells, and plays a role in Th1 cell differentiation. The up-regulation of this gene is found to be associated with a number of infectious diseases, such as Crohn's disease and leprosy, which is thought to contribute to the inflammatory response and host defense. Several transcript variants encoding different isoforms and non-protein coding transcripts have been found for this gene. [provided by RefSeq, Apr 2012]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 1-67321603-T-C is Benign according to our data. Variant chr1-67321603-T-C is described in ClinVar as Benign. ClinVar VariationId is 1169445.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.01 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.197 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001374259.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL12RB2
NM_001374259.2
MANE Select
c.78T>Cp.Asp26Asp
splice_region synonymous
Exon 4 of 17NP_001361188.1
IL12RB2
NM_001559.3
c.78T>Cp.Asp26Asp
splice_region synonymous
Exon 3 of 16NP_001550.1
IL12RB2
NM_001258215.1
c.78T>Cp.Asp26Asp
splice_region synonymous
Exon 3 of 14NP_001245144.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL12RB2
ENST00000674203.2
MANE Select
c.78T>Cp.Asp26Asp
splice_region synonymous
Exon 4 of 17ENSP00000501329.1
IL12RB2
ENST00000262345.5
TSL:1
c.78T>Cp.Asp26Asp
splice_region synonymous
Exon 3 of 16ENSP00000262345.1
IL12RB2
ENST00000544434.5
TSL:1
c.78T>Cp.Asp26Asp
splice_region synonymous
Exon 3 of 14ENSP00000442443.1

Frequencies

GnomAD3 genomes
AF:
0.0569
AC:
8650
AN:
152134
Hom.:
844
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.200
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0154
Gnomad ASJ
AF:
0.00317
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000397
Gnomad OTH
AF:
0.0406
GnomAD2 exomes
AF:
0.0157
AC:
3934
AN:
251054
AF XY:
0.0110
show subpopulations
Gnomad AFR exome
AF:
0.213
Gnomad AMR exome
AF:
0.00954
Gnomad ASJ exome
AF:
0.00347
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000502
Gnomad OTH exome
AF:
0.00522
GnomAD4 exome
AF:
0.00601
AC:
8642
AN:
1437514
Hom.:
793
Cov.:
27
AF XY:
0.00518
AC XY:
3716
AN XY:
716826
show subpopulations
African (AFR)
AF:
0.211
AC:
6895
AN:
32702
American (AMR)
AF:
0.0102
AC:
458
AN:
44684
Ashkenazi Jewish (ASJ)
AF:
0.00346
AC:
90
AN:
25986
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39604
South Asian (SAS)
AF:
0.000420
AC:
36
AN:
85742
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53250
Middle Eastern (MID)
AF:
0.00875
AC:
50
AN:
5716
European-Non Finnish (NFE)
AF:
0.000292
AC:
318
AN:
1090330
Other (OTH)
AF:
0.0134
AC:
795
AN:
59500
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
382
763
1145
1526
1908
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
212
424
636
848
1060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0570
AC:
8672
AN:
152252
Hom.:
845
Cov.:
32
AF XY:
0.0545
AC XY:
4054
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.200
AC:
8310
AN:
41500
American (AMR)
AF:
0.0154
AC:
235
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00317
AC:
11
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000397
AC:
27
AN:
68030
Other (OTH)
AF:
0.0402
AC:
85
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
355
710
1065
1420
1775
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
84
168
252
336
420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0220
Hom.:
931
Bravo
AF:
0.0650
Asia WGS
AF:
0.0140
AC:
49
AN:
3478
EpiCase
AF:
0.000382
EpiControl
AF:
0.000948

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

IL12RB2-related disorder Benign:1
May 02, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.58
CADD
Benign
2.5
DANN
Benign
0.50
PhyloP100
-1.0
Mutation Taster
=79/21
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00019
dbscSNV1_RF
Benign
0.0060
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2307147; hg19: chr1-67787286; API